Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (111-120 of 381) with videos related to

Pageof 39
Sort By:
The Journal of Dermatological Treatment|December 18, 2023
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life studySara Cacciapuoti, Matteo Megna, Emanuela Salza, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2022
Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to 'Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review' by Pauluzzi et alFabrizio Martora, Angelo Ruggiero, Teresa Battista, et al.
Clinical and Experimental Dermatology|March 8, 2023
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca, et al.
Medicina (Kaunas, Lithuania)|May 27, 2026
Hidradenitis Suppurativa and IL-17 Inhibitors: A Focus on Trials and Real-Life DataFabrizio Martora, Nello Tommasino, Valeria Esposito, et al.
Clinical, Cosmetic and Investigational Dermatology|July 31, 2023
Nail Psoriasis: An Updated Review of Currently Available Systemic TreatmentsTeresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
The Journal of Dermatological Treatment|May 15, 2020
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern ItalyClaudio Marasca, Angelo Ruggiero, Matteo Megna, et al.
International Journal of Dermatology|May 3, 2020
COVID-19 pandemic: University of Naples Federico II Dermatology's model of dermatology reorganizationAngela Patrì, Lucia Gallo, Maria C Annunziata, et al.
Journal of Cosmetic Dermatology|January 28, 2022
Long-term results of teledermatology for acne patients during COVID-19 pandemicAlessia Villani, Maria Carmela Annunziata, Matteo Megna, et al.
Case Reports in Dermatology|February 22, 2024
Atezolizumab-Induced Acrodermatitis and Pustular Psoriasis in a Patient with Non-Small Cell Lung Cancer: A Rare Case ReportDavide Fattore, Gianluca Esposito, Ludovica Carangelo, et al.
Journal of Cosmetic Dermatology|March 25, 2022
Teledermatology: A useful tool also after COVID-19 era?Matteo Megna, Elisa Camela, Alessia Villani, et al.
Pageof 39

Showing results (111-120 of 381) with videos related to

Sort By:
Pageof 39
The Journal of Dermatological Treatment|December 18, 2023
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life studySara Cacciapuoti, Matteo Megna, Emanuela Salza, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2022
Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to 'Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review' by Pauluzzi et alFabrizio Martora, Angelo Ruggiero, Teresa Battista, et al.
Clinical and Experimental Dermatology|March 8, 2023
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca, et al.
Medicina (Kaunas, Lithuania)|May 27, 2026
Hidradenitis Suppurativa and IL-17 Inhibitors: A Focus on Trials and Real-Life DataFabrizio Martora, Nello Tommasino, Valeria Esposito, et al.
Clinical, Cosmetic and Investigational Dermatology|July 31, 2023
Nail Psoriasis: An Updated Review of Currently Available Systemic TreatmentsTeresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
The Journal of Dermatological Treatment|May 15, 2020
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern ItalyClaudio Marasca, Angelo Ruggiero, Matteo Megna, et al.
International Journal of Dermatology|May 3, 2020
COVID-19 pandemic: University of Naples Federico II Dermatology's model of dermatology reorganizationAngela Patrì, Lucia Gallo, Maria C Annunziata, et al.
Journal of Cosmetic Dermatology|January 28, 2022
Long-term results of teledermatology for acne patients during COVID-19 pandemicAlessia Villani, Maria Carmela Annunziata, Matteo Megna, et al.
Case Reports in Dermatology|February 22, 2024
Atezolizumab-Induced Acrodermatitis and Pustular Psoriasis in a Patient with Non-Small Cell Lung Cancer: A Rare Case ReportDavide Fattore, Gianluca Esposito, Ludovica Carangelo, et al.
Journal of Cosmetic Dermatology|March 25, 2022
Teledermatology: A useful tool also after COVID-19 era?Matteo Megna, Elisa Camela, Alessia Villani, et al.
Pageof 39